These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5020742)

  • 21. [Cellular immunotherapy in advanced carcinoma of the breast by means of tumour antigen-specific autologous T-memory bone marrow cells as a phase I study].
    Schütz F
    Zentralbl Gynakol; 2004 Dec; 126(6):365-7. PubMed ID: 15570551
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immunity to tumor-associated antigens in man.
    Hellström KE; Hellström I
    N Engl J Med; 1977 Apr; 296(15):874-5. PubMed ID: 321957
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).
    Vetvicka V; Thornton BP; Wieman TJ; Ross GD
    J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
    Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
    [No Abstract]   [Full Text] [Related]  

  • 26. The cellular protein p53 in human tumours.
    Crawford LV; Pim DC; Lamb P
    Mol Biol Med; 1984 Aug; 2(4):261-72. PubMed ID: 6544917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer -- a randomized controlled clinical trial.
    Billhult A; Lindholm C; Gunnarsson R; Stener-Victorin E
    Auton Neurosci; 2008 Jun; 140(1-2):88-95. PubMed ID: 18474451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-antigen does not induce cell mediated immunity in patients with breast cancer.
    Howard DR
    Cancer; 1983 Jun; 51(11):2053-6. PubMed ID: 6839295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
    Toso JF; Oei C; Oshidari F; Tartaglia J; Paoletti E; Lyerly HK; Talib S; Weinhold KJ
    Cancer Res; 1996 Jan; 56(1):16-20. PubMed ID: 8548758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of tumour infiltrating lymphocytes in human breast cancer.
    Chin Y; Janssens J; Bleus J; Vandepitte J; Vandenbrande J; Raus J
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():27-31. PubMed ID: 8298448
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological and pathobiological roles of fibulin-1 in breast cancer.
    Pupa SM; Argraves WS; Forti S; Casalini P; Berno V; Agresti R; Aiello P; Invernizzi A; Baldassari P; Twal WO; Mortarini R; Anichini A; Ménard S
    Oncogene; 2004 Mar; 23(12):2153-60. PubMed ID: 14691454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.
    Larkin A; Moran E; Kennedy SM; Clynes M
    J Immunol Methods; 2005 Aug; 303(1-2):53-65. PubMed ID: 16038928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
    Peoples GE; Anderson BW; Lee TV; Murray JL; Kudelka AP; Wharton JT; Ioannides CG
    Clin Cancer Res; 1999 Dec; 5(12):4214-23. PubMed ID: 10632363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood group T and Tn antigens are universal, clonal, epithelial cell-adhesive, autoimmunogenic carcinoma markers.
    Springer GF
    Prog Clin Biol Res; 1983; 133():157-66. PubMed ID: 6622492
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the inhibitory effects of lymphocytes from patients with and without cancer on the growth of human tumour cells in culture.
    Jamieson CW
    Br J Surg; 1972 Apr; 59(4):302. PubMed ID: 5020745
    [No Abstract]   [Full Text] [Related]  

  • 36. [The significance of immunological investigations during radiotherapy for breast cancer (author's transl)].
    Boller B; Kärcher KH
    Wien Klin Wochenschr; 1981 Sep; 93(17):547-51. PubMed ID: 7303701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immune response to basal cell carcinoma.
    Raffle EJ; MacLeod TM; Hutchinson F
    Acta Derm Venereol; 1981; 61(1):66-8. PubMed ID: 6164220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunofluorescence studies on sera of patients with breast carcinoma.
    Priori ES; Seman G; Dmochowski L; Gallager HS; Anderson DE
    Cancer; 1971 Dec; 28(6):1462-71. PubMed ID: 4108410
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.